We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CMRX market cap is 300.39M. The company's latest EPS is USD -0.9128 and P/E is -3.66.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 11k | 4k | 0 | 129k | 26k |
| Operating Income | -26.69M | -20.81M | -24.39M | -22.83M | -24.79M |
| Net Income | -23.99M | -18.16M | -21.87M | -20.69M | -22.88M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 12.52M | 5.37M | 1.98M | 33.82M | 324k |
| Operating Income | -115.98M | -44.52M | -173.4M | -60.39M | -93.07M |
| Net Income | -112.58M | -43.52M | -173.24M | 172.17M | -82.1M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 225.28M | 212.77M | 194.04M | 178.51M | 158.67M |
| Total Liabilities | 16.98M | 19.75M | 19.94M | 22.93M | 22.89M |
| Total Equity | 208.3M | 193.03M | 174.1M | 155.58M | 135.78M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 119.38M | 84.72M | 100.54M | 279.34M | 212.77M |
| Total Liabilities | 9.42M | 11.35M | 32.29M | 22.48M | 19.75M |
| Total Equity | 109.95M | 73.38M | 68.25M | 256.86M | 193.03M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -54.5M | -69.09M | -17.52M | -35.2M | -55.71M |
| Investing | 42.53M | 70.6M | 8.68M | 23.03M | 51.35M |
| Financing | 246k | 308k | 208k | 166k | 344k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -75.18M | -36.04M | -99.93M | -46.87M | -69.09M |
| Investing | 10.63M | 64.71M | -44.09M | 70.04M | 70.6M |
| Financing | 345k | 1.41M | 112.43M | -12.73M | 308k |
| Market Cap | 300.39M |
| Price to Earnings Ratio | -3.66 |
| Price to Sales Ratio | 927.78 |
| Price to Cash Ratio | 10.86 |
| Price to Book Ratio | 1.56 |
| Dividend Yield | - |
| Shares Outstanding | 89.94M |
| Average Volume (1 week) | 1.86M |
| Average Volume (1 Month) | 12.09M |
| 52 Week Change | 256.15% |
| 52 Week High | 3.39 |
| 52 Week Low | 0.75 |
| Spread (Intraday) | 0.09 (2.69%) |
| Company Name | Chimerix Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.chimerix.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
